What question did this study set out to answer?

April 24, 2026Open Access

The Association Between C-Reactive Protein-to-Albumin Ratio and in-Hospital Mortality in Patients with Klebsiella pneumoniae Bloodstream Infection: A Retrospective Cohort Study

Key Points

This research aims to evaluate the relationship between C-reactive protein-to-albumin ratio and in-hospital mortality in patients with Klebsiella pneumoniae bloodstream infection.
Analyzed data from 264 patients with Klebsiella pneumoniae bloodstream infection at a medical center from 2019 to 2024.
Categorized patients into tertiles based on C-reactive protein-to-albumin ratio and assessed mortality risk using Cox proportional hazards models and Kaplan–Meier survival curves.
Conducted subgroup and sensitivity analyses to explore the robustness of findings.
45.8% of patients died during hospitalization, with non-survivors having a significantly higher CAR than survivors.
Each unit increase in CAR was associated with a 12% higher risk of in-hospital mortality.
Patients in the highest CAR tertile showed over three times the mortality risk compared to those in the lowest tertile.

Abstract

Background: The C-reactive protein-to-albumin ratio (CAR), integrating inflammation (CRP) and physiological reserve (albumin), shows promise as a prognostic biomarker in critical illness, but its specific role in Klebsiella pneumoniae bloodstream infection (KP-BSI) mortality has not been confirmed. Methods: Between 2019 and 2024, 264 adult patients with KP-BSI at a tertiary medical center were included in this retrospective cohort study. The primary endpoint was in-hospital mortality, Patients were categorized into three groups according to tertiles of the CAR: T1 6.91. To assess the relationship between serum CAR levels and mortality risk, we applied multivariable Cox proportional hazards models and constructed Kaplan–Meier survival curves, with subgroup analyses incorporating interaction testing across sex, age, diabetes, septic shock, and CRKP status, as well as sensitivity analyses excluding patients with chronic liver disease, those with missing covariates, and including those with a length of hospital stay exceeding 180 days. The discriminatory performance of CAR was further assessed using receiver operating characteristic (ROC) curve analysis. Results: Among the 264 patients included in the final analysis, 121 (45.8%) died during hospitalization. Non-survivors showed significantly higher CAR (7.1 ± 3.4) than survivors (4.8 ± 3.0) (p< 0.001). After adjusting for potential confounders, each unit increase in CAR was independently associated with a higher risk of in-hospital mortality (hazard ratio (HR)=1.12, 95% confidence interval (CI): 1.07– 1.19, p< 0.001). When treated as a categorical variable, compared to the reference group (T1 group), patients in the highest tertile (T3) had a substantially elevated mortality risk (HR=3.12, 95% CI: 1.83– 5.34, P< 0.001). Subgroup analyses and sensitivity analyses consistently supported the robustness of the results. The ROC analysis demonstrated that CAR had moderate discriminatory ability. Conclusion: CAR is independently associated with in-hospital mortality in patients with KP-BSI. This readily available biomarker offers meaningful early risk stratification and may help identify patients at elevated risk who could benefit from closer monitoring and targeted clinical intervention. Keywords: Klebsiella pneumoniae , bloodstream infection, C-reactive protein, albumin, CAR

KI fragen

Bookmark

View Full Paper